Featured Courses

Real World Considerations for I-131 MIBG | myCME

AMA PRA Category 1 Credit(s)^TM

0.50 CME: Reviews evidence for approval of HAS I-131-MIBG and best practices for preparing patients, executing dosimetry and therapy. Exp 11/30/2022

Clinical Conversations on Diabetes Technology – An AACE Guidelines Update

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

This activity is designed to equip adult primary care clinicians with evidence-based knowledge and increased competence about how to use diabetes technology and devices to guide and modify treatment approaches for patients with diabetes.

Hereditary Pheochromocytoma and Paraganglioma

AMA PRA Category 1 Credit(s)^TM

The goal of this activity is to provide clinicians with a brief review of hereditary paraganglioma-pheochromocytoma syndrome, SDHD-Associated tumor risks, and surveillance recommendations.

Diabetic Peripheral Neuropathy with L-Methylfolate | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

1.00 CME CE: L-methylfolate is safe and effective to treat the underlying causes of diabetic peripheral neuropathy and provide sustained relief. Exp 5/24/2023

A New Frontier in the Comanagement of TED | myCME

AMA PRA Category 1 Credit(s)^TM

In this activity, faculty explore the role of nonpharmacologic, pharmacologic and surgical options for thyroid eye disease and discuss how to implement strategies that help patients with thyroid eye disease improve their quality of life.

New Technologies to Optimize Diabetes Management | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists, AAPA Category I CME credit, CPEU Credit, CNE Contact Hour(s)

1.00 CME CE: Highlights current and emerging digital technology that aims to help better manage patients on insulin therapy. Exp 11/11/2022

Key Updates in Obesity Management for Primary Care | myCME

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Points, ANCC Contact Hour(s)

1.00 CME CE: Helps formulate a management plan that includes steps and strategies supporting optimal PCP-endocrinologist collaboration. Exp 1/24/23

Primary Care and Dyslipidemia: What Should You Do? | myCME

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Points, ANCC Contact Hour(s)

1.00 CME CE: An interactive module focusing on identifying the types (LDL, TC, triglycerides), atherosclerosis, treatment, and when to refer. Exp 1/24/23

Thyroid Assessment: Updates for Primary Care | myCME

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Points, ANCC Contact Hour(s)

1.00 CME CE: An interactive module focusing on the assessment, diagnosis, and treatment of patients with a thyroid disorder. Exp 1/24/23

Osteoporosis Updates: Primary Care’s Critical Role | myCME

AMA PRA Category 1 Credit(s)^TM, ABIM MOC Points, ANCC Contact Hour(s)

1.00 CME CE: Explores bone conditions often encountered in primary care and also provides information for when to refer to an endocrinologist. Exp 1/24/23

Breast Cancer Racial Disparities in Endocrine Therapy | myCME

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s), IPCE Credit(s), CE for Social Worker, CE for Pharmacists

1.00 CME CE: Black women with hormone receptor-positive BC experience the greatest disparity in survival among all breast cancer subtypes. Exp 2/4/23

Growth Hormone Therapy in the Pediatric Setting | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists, AAPA Category I CME credit, ABIM MOC Points

1.00 CME CE: Experts in growth disorders present patient cases to illustrate real-world challenges and contemporary GHD management. Exp 2/14/23